Ismail Ceylan

Title: Ismail Ceylan: Innovator in Biodesign

Introduction

Ismail Ceylan is a notable inventor based in Saint-Priest, France. He has made significant contributions to the field of biodesign, particularly in the development of diagnostic markers and methods for monitoring biological processes. With a total of 3 patents to his name, Ceylan's work is at the forefront of innovation in his field.

Latest Patents

Ceylan's latest patents include a specific substrate of an ALDH isoenzyme. This invention relates to a specific substrate on an ALDH isoenzyme, a composition comprising at least one such substrate, a diagnostic marker comprising such a substrate, and the associated methods and uses. Another significant patent is for a monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis. This invention concerns an ex vivo method for monitoring apoptosis based on the detection of free gamma-glutamyl-L-epsilon-Lysine (GGEL) in a biological sample, utilizing a monoclonal antibody specific to GGEL. It also includes diagnostic kits containing such a ligand.

Career Highlights

Ismail Ceylan is currently associated with Advanced Biodesign, where he applies his expertise to advance the field of biodesign. His innovative work has positioned him as a key player in the development of new diagnostic tools and methods.

Collaborations

Ceylan collaborates with notable colleagues such as Guillaume Martin and Gerry Quash, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Ismail Ceylan's contributions to biodesign through his patents and collaborative efforts highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in diagnostic methods and biological research.